
EastGate Biotech Announces Preparation to Initiate Phase III Clinical Trials on Insugin, its Liquid Insulin Mouth Rinse for Type 2 diabetes patients
Multi-Center Phase III trial planned for 2019
[…]
Multi-Center Phase III trial planned for 2019
[…]
PRINCETON, NJ – May 14, 2019 – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical […]
Company provides Q1 2019 update and guidance. Upcoming interview with WSA. […]
Following a 3-month treatment, significant Hb1c Reduction was observed with administration of a single dose of Insugin two times a day […]
DALLAS, TX, April 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NaturalShrimp, Inc. (SHMP) announced today that their order for two additional EC shrimp water treatment systems have arrived at their Lacoste, Texas, facility, near […]
The ongoing infill drilling program at the Marathon Deposit is designed to penetrate down through the main mineralized corridor as well as into the hanging wall and foot wall zones of the open pit. […]
Alliance with MJ Biopharm of Mumbai, India positions the company to further its plans for SEA countries for its liquid insulin mouth rinse […]
NEW YORK, March 05, 2019 (GLOBE NEWSWIRE) — Giga-tronics’ (OTCQB: GIGA) CFO Dr. Lutz Henckels provided an outline of GIGA’s two main product lines; Microwave components and their RADAR test business. On the Microwave component […]
Additional $1.15 million in working capital provided by a Canadian Schedule I bank with the support of Export Development Canada […]
“The success of new infill drill holes into the Marathon Deposit open-pit cannot be overstated”, said Phillip Walford, President and CEO of Marathon Gold. […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com